Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-Current Debt
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Change in Receivables: 2020-2024

Historic Change in Receivables for CureVac N.V (CVAC) over the last 4 years, with Sep 2024 value amounting to $20.1 million.

  • CureVac N.V's Change in Receivables rose 558.03% to $20.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.6 million, marking a year-over-year increase of 219.83%. This contributed to the annual value of -$8.7 million for FY2023, which is 189.70% down from last year.
  • CureVac N.V's Change in Receivables amounted to $20.1 million in Q3 2024, which was up 371.03% from -$7.4 million recorded in Q2 2024.
  • In the past 5 years, CureVac N.V's Change in Receivables registered a high of $10.2 billion during Q2 2022, and its lowest value of -$10.7 billion during Q1 2022.
  • For the 3-year period, CureVac N.V's Change in Receivables averaged around -$46.6 million, with its median value being -$782,937 (2023).
  • As far as peak fluctuations go, CureVac N.V's Change in Receivables surged by 562,317.01% in 2021, and later plummeted by 458,666.32% in 2022.
  • CureVac N.V's Change in Receivables (Quarterly) stood at -$1.6 million in 2020, then soared by 562,317.01% to $8.9 billion in 2021, then crashed by 100.03% to -$2.9 million in 2022, then crashed by 141.68% to -$7.0 million in 2023, then surged by 558.03% to $20.1 million in 2024.
  • Its Change in Receivables stands at $20.1 million for Q3 2024, versus -$7.4 million for Q2 2024 and -$106,463 for Q1 2024.